| Literature DB >> 24693057 |
Abstract
Mesenchymal stem cells (MSCs), are multipotent stem cells that can differentiate into osteoblasts, chondrocytes, myocytes and adipocytes. We utilized adipose tissue as our primary source, since it is a rich source of MSCs as well as it can be harvested using a minimally invasive surgical procedure. Both visceral and subcutaneous adipose tissue (VSAT, SCAT respectively) samples were cultured using growth medium without using any substratum for their attachment. We observed growth of mesenchymal like cells within 15 days of culturing. In spite of the absence of any substratum, the cells adhered to the bottom of the petri dish, and spread out within 2 hours. Presently VSAT cells have reached at passage 10 whereas; SCAT cells have reached at passage 14. Morphologically MSCs obtained from visceral adipose tissue were larger in shape than subcutaneous adipose tissue. We checked these cells for presence or absence of specific stem cell molecular markers. We found that VSAT and SCAT cells confirmed their MSC phenotype by expression of specific MSC markers CD 105 and CD 13 and absence of CD34 and CD 45 markers which are specific for haematopoietic stem cells. These cells also expressed SOX2 gene confirming their ability of self-renewal as well as expressed OCT4, LIF and NANOG for their properties for pluripotency & plasticity. Overall, it was shown that adipose tissue is a good source of mesenchymal stem cells. It was also shown that MSCs, isolated from adipose tissue are multipotent stem cells that can differentiate into osteoblasts, chondrocytes, cardiomyocytes, adipocytes and liver cells which may open a new era for cell based regenerative therapies for bone, cardiac and liver disorders.Entities:
Keywords: Stem cells; adipose tissue; mesenchymal stem cells; molecular markers
Year: 2010 PMID: 24693057 PMCID: PMC3908252
Source DB: PubMed Journal: J Stem Cells Regen Med ISSN: 0973-7154
Shows sequences of primers used for respective molecular markers
| Sr. | Molecular | Forward primer (5’-3’) | Reverse primer (5’-3’) |
| 1 | CD105 | TGTCTCACTTCATGCCTCCAGCT | AGGCTGTCCATGTTGAGGCAGT |
| 2 | CD13 | GTCTACTGCAACGCTATCGC | GATGGACACATGTGGGCACCTTG |
| 3 | CD34 | GCAAGCCACCAGAGCTATTC | GGTCCCAGGTCCTGAGCTAT |
| 4 | CD45 | ACCAGGGGTTGAAAAGTTTCAG | GGGATTCCAGGTAATTACTCC |
| 5 | LIF | GGCCCGGACACCCATAGACG | CCACGCGCCATCCAGGTAAA |
| 6 | SOX2 | GCCGAGTGGAAACTTTTGTC | GTTCATGTGCGCGTAACTGT |
| 7 | Oct-4 | GAGCAAAACCCGGAGGAGT | TTCTCTTTCGGGCCTGCAC |
| 8 | NANOG | GCTTGCCTTGCTTTGAAGCA | TTCTTGACCGGGACCTTGTC |
| 9 | Keratin18 | GAGATCGAGGCTCTCAAGGA | CAAGCTGGCCTTCAGATTTC |
| 10 | β- Actin | AACCCCAAGGCCAACCGCGAGAAGATGACC | GGTGATGACCTGGCCGTCAGGCAGCTCGTA |
Shows all the PCR programs used for respective molecular markers. 40 cycles were carried out for denaturation, annealing and extension in each PCR program.
| Sr | Gene | Initial | Denaturation | Annealing | Extension | Final | Forever |
| Time | 5 mins | 30 sec | 30 sec | 1 min | 10 mins | ||
| 1 | CD105 | 95°C | 94°C | 60°C | 72°C | 72°C | 4°C |
| 2 | CD13 | 95°C | 94°C | 60°C | 72°C | 72°C | 4°C |
| 3 | CD45 | 95°C | 94°C | 60°C | 72°C | 72°C | 4°C |
| 4 | CD34 | 95°C | 94°C | 57°C | 72°C | 72°C | 4°C |
| 5 | NANOG | 95°C | 94°C | 57°C | 72°C | 72°C | 4°C |
| 6 | Oct-4 | 95°C | 94°C | 57°C | 72°C | 72°C | 4°C |
| 7 | SOX2 | 95°C | 94°C | 57°C | 72°C | 72°C | 4°C |
| 8 | LIF | 95°C | 94°C | 57°C | 72°C | 72°C | 4°C |
| 9 | keratin | 95°C | 94°C | 57°C | 72°C | 72°C | 4°C |
| 10 | Actin | 95°C | 94°C | 57°C | 72°C | 72°C | 4°C |
Figure 1Shows visceral adipose tissue mesenchymal stem cells (VSAT) having large nucleus and extended cytoplasm
Figure 2Shows subcutaneous adipose tissue mesenchymal stem cells (SCAT), which aremore elongated morphology with nucleus and cytoplasm
Figure 3Shows colony formation having aggregation of cells observed in subcutaneous adipose tissue mesenchymal stem cell culture at passage 8
Figure 4Shows Giemsa stained subcutaneous adipose tissue mesenchymal stem cells having large nucleus and cytoplasm
Shows expression of molecular markers in the samples of normal blood, cord blood 1, cord blood 2, umbilical cord tissue, aphaeresis blood, cultured VSAT cells and cultured SCAT cells as well as positive control samples used. Key: +: Expressed -: Not Expressed, NC- Not Checked CML: Chronic Myeloid Leukaemia, NBS: Normal Blood Sample
| Sample | CD105 | CD13 | CD45 | CD34 | LIF | SOX2 | 4- | NANOG | Keratin |
| Positive | CML | CML | CML | CML | NBS | CML | NBS | NBS | NBS |
| Normal | - | - | - | - | + | + | + | + | + |
| Cord blood | - | - | - | - | + | + | + | + | + |
| Cord blood | - | - | - | - | + | + | + | + | + |
| Umbilical | - | - | - | - | + | - | + | + | + |
| Adipose | - | - | - | + | + | - | + | + | + |
| Aphaeresis | - | - | - | - | + | - | + | + | + |
| VSAT | + | + | - | - | + | + | + | NC | + |
| SCAT | + | + | - | - | + | + | + | NC | + |
Figure 5Shows expression of molecular markers in samples of normal blood, cord blood, umbilical cord tissue, adipose tissue, aphaeresis blood, VSAT cells and SCAT cells
Shows positive control used and expression of given molecular markers in cultured VSAT and SCAT cells at various passages key- +: Expressed, -: Not Expressed, CML: Chronis Myeloid Leukaemia, NBS: Normal Blood Sample
| Molecular | Positive | Visceral | VSAT | VSAT | SCAT | SCAT |
| CD105 | CML + | - | + | + | + | + |
| CD13 | CML + | - | + | - | + | + |
| CD34 | CML + | - | + | - | + | - |
| CD45 | CML + | - | - | - | + | - |
| LIF | NBS + | + | + | + | + | + |
| SOX2 | CML + | - | + | - | + | + |
| Keratin18 | NBS + | + | + | + | + | + |
| Oct-4 | NBS + | + | + | - | + | + |
| NANOG | NBS + | + | + | - | + | + |
| Actin | NBS + | + | + | + | + | + |